The goal is to detect any new or recurrent tumors early when they are most treatable. This surveillance typically involves cystoscopy, urine cytology, and imaging studies at specific intervals dictated by the treatment schedule.
BCG Therapy Candidacy Evaluation Process: Understanding Your Eligibility
Induction and Maintenance Phases Induction: Weekly instillations for six consecutive weeks to establish an initial immune response. More serious complications, although rare, can include systemic infection or bladder scarring.
Intravesical therapy with Bacillus Calmette-Guérin, or BCG, remains the gold standard treatment for preventing recurrence and progression in non-muscle-invasive bladder cancer. Urologists generally reserve this treatment for individuals classified as having intermediate or high risk of recurrence or progression.
BCG Therapy Candidacy Evaluation Process
This organ-sparing advantage is a significant reason why the treatment remains a preferred option in the oncology community. This maintenance phase can extend for one to three years, involving instillations at longer intervals, such as once a week for three weeks every three months.
More About Intravesical therapy bcg
Looking at Intravesical therapy bcg from another angle can help expand the discussion and give readers a second clear paragraph under the same section.
More perspective on Intravesical therapy bcg can make the topic easier to follow by connecting earlier points with a few simple takeaways.
